The University of Chicago Header Logo

A novel tumor inhibitory hybridoma monoclonal antibody with dual specificity for HER3 and HER2.

A novel tumor inhibitory hybridoma monoclonal antibody with dual specificity for HER3 and HER2. Curr Res Transl Med. 2021 05; 69(2):103277.

View in: PubMed